Concurrent Pembrolizumab With Standard Chemotherapy for Untreated Classical Hodgkin Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Concurrent pembrolizumab with AVD for untreated classical Hodgkin lymphoma
Blood 2023 Mar 13;[EPub Ahead of Print], RC Lynch, CS Ujjani, C Poh, EH Warren, SD Smith, M Shadman, BG Till, V Raghunathan, S Alig, AA Alizadeh, A Gulhane, D Chen, Y Tseng, H Coye, M Shelby, S Ottemiller, S Keo, K Verni, H Du, J Vandermeer, A Gaston, H Rasmussen, P Martin, E Marzbani, JM Voutsinas, AK GopalFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.